Skip Navigation

JNCI Journal of the National Cancer Institute 2006 98(21):1582; doi:10.1093/jnci/djj416
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Gibbs, P.
Right arrow Articles by Faragher, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gibbs, P.
Right arrow Articles by Faragher, I.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press.

CORRESPONDENCE

Re: Completion of Therapy by Medicare Patients With Stage III Colon Cancer

Peter Gibbs, Stephen McLaughlin, Iain Skinner, Ian Jones, Ian Hayes, Matthew Chapman, Julie Johns, Lionel Lim, Ian Faragher

Affiliations of authors: Department of Medical Oncology, Royal Melbourne Hospital and Western Hospital, Victoria, Australia (PG, LL); Department of Colorectal Surgery, Royal Melbourne Hospital, Victoria, Australia (IJ, IH); Department of Colorectal Surgery, Western Hospital, Victoria, Australia (SM, IS, IF); Ludwig Institute of Cancer Research, Victoria, Australia (PG, MC, JJ, LL)

Correspondence to: Peter Gibbs, MD, Oncology, Royal Melbourne Hospital, Grattan St., Parkville, Victoria 3050, Australia (e-mail: peter.gibbs@mh.org.au).

The first 10% of the full text of this article appears below.

We read with interest the article by Dobie et al. (1). These investigators linked data from the Surveillance, Epidemiology, and End Results program to Medicare claims and attempted to address the important questions: what percentage of patients in routine clinical practice fail to complete adjuvant treatment for stage III colon cancer and what are . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?